Additional information
| Water Retention | Low risk of water retention |
|---|---|
| Hepatotoxicity | Rare hepatotoxic effects |
| Lab Test | Monitoring of serum potassium and renal function recommended |
| Strength | 2.5 MG |
| Also known as | Enalapril maleate |
| Blood pressure | Reduces systolic and diastolic blood pressure |
| Trade name | Vasotec, Renitec, Enacard |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (2S)-1-[N-[(S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline, dihydrate |
| Formula | C20H28N2O5В·2H2O |
| Substance class | Angiotensin-converting enzyme (ACE) inhibitor |
| Main action | Lowers blood pressure by inhibiting the conversion of angiotensin I to angiotensin II |
| Half-life | Approximately 11 hours |
| Dosage (medical) | Typically starts at 5 mg once daily, adjusted as needed |
| Dosage (sports) | Not applicable |
| Effects | Reduction in blood pressure, improved heart function |
| Side effects | Cough, hypotension, dizziness, headache, fatigue |
| Use in sports | Not typically used in sports |
| Manufacturer | Intas Pharmaceuticals |
Fostimon (Merional) 75 (HMG) IBSA
FACTIVE 320 mg Abdi Ibragim
AVELOX 400 Bayer
Zyban Glaxosmithkline
Spiriva HandiHaler 18mg Boehringer Ingelheim
Zimaks 400 Bilim
Fostimon (Merional) 150 IU HMG IBSA
Januvia 100mg Merckgroup
LACIPIL 4 mg Glaxosmithkline 

Reviews
There are no reviews yet.